Christine Ring, Chief Legal Officer at Nurix Therapeutics, Inc. (NRIX), sold 8,842 shares at $16.58 ($147K) on 2026-01-30, disclosed to the SEC on 2026-01-30.
Open-market sale of $147k NRIX by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.58 | 4,333 | $72K | 49.0% |
| 2 | $16.58 | 4,333 | $72K | 49.0% |
| 3 | $17.37 | 88 | $2K | 1.0% |
| 4 | $17.37 | 88 | $2K | 1.0% |
| Total | $16.60 avg | 8,842 | $147K | 100% |
| Filing → |
| NRIX | SELL | 2026-08-03 | $382K | — | Filing → |
| NRIX | SELL | 2026-07-30 | $90K | — | Filing → |
| NRIX | SELL | 2026-07-02 | $259K | — | Filing → |